Encompass Health CFO tax-withholds 14,818 shares

Encompass Health Corp EVP & Chief Financial Officer Douglas E. Coltharp reported a Form 4 transaction involving Encompass Health Common Stock.

Rhea-AI Filing Summary

Encompass Health Corp EVP & Chief Financial Officer Douglas E. Coltharp reported a Form 4 transaction involving Encompass Health Common Stock. On February 23, 2026, 14,818 shares were disposed of at $106.15 per share under code F, which indicates a tax-withholding disposition to satisfy tax obligations tied to vesting restricted stock, rather than an open-market sale. After this withholding event, he directly owns 70,153 shares, with additional indirect holdings reported through an irrevocable trust, an irrevocable trust for the benefit of his children, and his spouse.

Insider Trade Summary

Exercise Price or Tax Liability: 14,818 shares

Exercise Price or Tax Liability 4 txns

Insider COLTHARP DOUGLAS E

Role EVP & Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Encompass Health Common Stock	14,818	$106.15	$1.57M
holding	Encompass Health Common Stock	--	--	--
holding	Encompass Health Common Stock	--	--	--
holding	Encompass Health Common Stock	--	--	--

Holdings After Transaction: Encompass Health Common Stock — 70,153 shares (Direct); Encompass Health Common Stock — 27,480 shares (Indirect, By irrevocable trust); Encompass Health Common Stock — 125,631 shares (Indirect, By irrevocable trust for the benefit of children); Encompass Health Common Stock — 37,749 shares (Indirect, By spouse)

Footnotes (1)

1. F1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

FAQ

What insider transaction did Encompass Health (EHC) report for Douglas Coltharp?

Douglas E. Coltharp reported a tax-withholding share disposition. On February 23, 2026, 14,818 Encompass Health shares were withheld at $106.15 per share to cover tax obligations from vesting restricted stock, not as an open-market sale.

How many Encompass Health (EHC) shares did the CFO dispose of for taxes?

The CFO had 14,818 shares withheld for taxes. These Encompass Health shares were surrendered at $106.15 per share in a Form 4 code F transaction to satisfy tax withholding from the vesting of related restricted stock.

How many Encompass Health (EHC) shares does the CFO own after this Form 4?

After the transaction, the CFO directly owns 70,153 shares. The filing also reports indirect ownership of 27,480 shares via an irrevocable trust, 125,631 shares via a children’s trust, and 37,749 shares held by his spouse.

Was the Encompass Health (EHC) CFO’s Form 4 transaction an open-market sale?

No, the transaction was not an open-market sale. The Form 4 uses code F and a footnote stating the 14,818 shares were withheld or surrendered solely to pay tax withholding obligations from vesting restricted stock.

What does transaction code F mean in the Encompass Health (EHC) Form 4?

Code F indicates a tax-withholding disposition. In this case, 14,818 Encompass Health shares were delivered to cover the insider’s tax liability related to vesting restricted stock, rather than being sold on the open market for investment purposes.

What indirect Encompass Health (EHC) holdings does the CFO report?

The CFO reports several categories of indirect ownership. The Form 4 lists 27,480 shares held by an irrevocable trust, 125,631 shares by an irrevocable trust for his children’s benefit, and 37,749 shares held by his spouse, in addition to his direct holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/25/2026 - 09:18 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

COLTHARP DOUGLAS E

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	02/23/2026		F		14,818(1)	D	$106.15	70,153	D
Encompass Health Common Stock								27,480	I	By irrevocable trust
Encompass Health Common Stock								125,631	I	By irrevocable trust for the benefit of children
Encompass Health Common Stock								37,749	I	By spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

	/s/ Patrick Darby, attorney-in-fact for Mr. Coltharp	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.